Evaluation of the HIV drug resistance surveillance system in Mozambique, 2017-2018

In the past ten years, the prevalence of primary Human Immunodeficiency Virus (HIV) drug resistance has ranged from zero to 25%, with higher and increasing rates in countries with access to antiretroviral therapy (ART), a specific case in Mozambique. World Health Organization (WHO) recommended that...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuvunga, Samuel, Langa, Denise Chitsondzo, Baltazar, Cynthia Semá, Sacarlal, Jahit, Rossetto, Erika, Vubil, Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2022
Materias:
Program Evaluation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941613/
https://www.ncbi.nlm.nih.gov/pubmed/36825120
http://dx.doi.org/10.11604/pamj.2022.43.162.29206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941613/
https://www.ncbi.nlm.nih.gov/pubmed/36825120
http://dx.doi.org/10.11604/pamj.2022.43.162.29206

Ejemplares similares